Slide 1: Exchange filing cover letter for earnings presentation
April 26, 2025 DCS-CRD Listing Compliance BSE Limited National Stock Exchange of India Limited First Floor, New Trade Wing Exchange Plaza, 5th Floor Rotunda Building, Phiroze Jeejeebhoy Towers Plot No. C/1, ‘G’ Block, Bandra- Kurla Dalal Street, Fort Mumbai 400001 Complex Bandra East Mumbai 400051 F
Slide 2: Q4 & FY25 Results Presentation
ROSSARI BIOTECH LIMITED Q4 & FY25 RESULTS PRESENTATION April 25, 2025
Slide 3: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to b
Slide 4: Q4 FY25 Results Overview, Company Overview, Annexure
1 Q4 FY25 Results Overview 2 Company Overview 3 Annexure
Slide 5: Q4 FY25 – Key Financial Highlights
Q4 FY25 – Key Financial Highlights Steady Quarterly Performance Strong Quarterly Revenue Highest Quarterly EBITDA Steady Quarterly PAT Revenue from Operations (Rs. cr) EBITDA (Rs. cr) PAT (Rs. cr) 69.5 64.8 63.6 579.6 34.4 34.1 512.7 472.7 31.7 Q4 FY25 Q3 FY25 Q4 FY24 Q4 FY25 Q3 FY25 Q4 FY24 Q4 FY25
Slide 6: FY25 – Key Financial Highlights
FY25 – Key Financial Highlights Highest Annual Revenue Highest Annual EBITDA Steady Annual PAT Revenue from Operations (Rs. cr) EBITDA (Rs. cr) PAT (Rs. cr) 2,080.3 265.1 249.8 1,830.6 136.4 130.7 FY25 FY24 FY25 FY24 FY25 FY24 Shift % (Y-o-Y) 13.6% 6.1% 4.4% Margins (%) 12.7% 13.6% 6.6% 7.1% Busines
Slide 7: Institutional and B2C Performance – Incubating Future Growth Verticals
Institutional and B2C Performance – Incubating Future Growth Verticals in Health & Hygiene Revenue (Rs. cr) EBITDA (Rs. cr) CAGR – 95% 299 7 179 3 79 FY23 FY24 FY25 FY23 FY24 FY25 -3 Shift % (Y-o-Y) 126.6% 67.0% 133.3% N.A. Margins (%) 3.8% 3.9% -1.0% • Institutional and B2C businesses registered st
Slide 8: Consolidated Performance excluding Institutional and B2C Segments
Consolidated Performance excluding Institutional and B2C segments Revenue (Rs. cr) EBITDA (Rs. cr) CAGR – 6% CAGR – 10% 1,652 1,781 1,577 268 220 243 FY23 FY24 FY25 FY23 FY24 FY25 Shift % (Y-o-Y) 4.8% 7.8% 10.5% 10.3% Margins (%) 13.9% 14.7% 15.0% • Core segments delivered resilient performance desp
Slide 9: Past Financial Performance Snapshot
Past Financial Performance Snapshot Revenue (Rs. cr) EBITDA (Rs. cr) PAT (Rs. cr) CAGR – 12% CAGR – 13% CAGR – 12% 250 265 131 136 2,080 223 1,656 1,831 98 107 1,483 183 FY22 FY23 FY24 FY25 FY22 FY23 FY24 FY25 FY22 FY23 FY24 FY25 Exports (Rs. cr) ROE (%) ROCE (%) Net Debt to Equity (x) CAGR – 29% 57
Slide 10: Management Message
Management Message Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We concluded the year with a steady performance, navigating a soft and evolving operating environment. Revenues grew by
Slide 11: Key Developments
Key Developments Capex initiatives to strengthen growth capabilities • Additional capex of Rs. 192 crore announced for capacity expansion at Rossari and subsidiaries: Rossari to expand by 13,000 MTPA; Unitop to add 18,500 MTPA; Tristar to expand by 3,600 MTPA • Projects aimed at supporting growth ac
Slide 12: Abridged P&L Statement - Consolidated
Abridged P&L Statement - Consolidated Particulars (Rs. cr) Q4 FY25 Q4 FY24 Y-o-Y FY25 FY24 Y-o-Y Revenues from Operations 579.6 472.7 22.6% 2,080.3 1,830.6 13.6% Total Expenditure COGS 401.6 338.3 18.7% 1,433.3 1,293.5 10.8% Employee benefits expense 35.6 25.0 42.4% 132.3 103.1 28.3% Other expenses
Slide 13: Consolidated Balance Sheet
Consolidated Balance Sheet ASSETS EQUITY AND LIABILITIES As on 31st March As on 31st March As on 31st March As on 31st March Particulars (Rs. cr) Particulars (Rs. cr) 2025 (Audited) 2024 (Audited) 2025 (Audited) 2024 (Audited) ASSETS EQUITY NON-CURRENT ASSETS Equity Share Capital 11.1 11.0 Property,
Slide 14: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement As on 31st As on 31st As on 31st As on 31st Particulars (Rs. cr) March 2025 March 2024 Particulars (Rs. cr) March 2025 March 2024 (Audited) (Audited) (Audited) (Audited) A. Cash flows from operating activities B. Cash flows from investing activities Profit before tax
Slide 15: Segment-wise Operating Performance
Segment-wise Operating Performance Quarterly Revenue Break-up (Rs. cr) YTD Revenue Break-up (Rs. cr) Q4 FY24 Q3 FY25 Q4 FY25 FY24 FY25 580 2,080 513 1,831 473 1,590 444 390 1,369 345 94 95 98 354 375 34 28 38 108 115 HPPC TSC AHN TOTAL HPPC TSC AHN TOTAL Shift (Y-o-Y) % 28.7% 4.3% 11.8% 22.6% Shift
Slide 16: Company Overview
COMPANY OVERVIEW
Slide 17: Rossari – At a Glance
Rossari – At a Glance Technocrat promoters with 45+ cumulative years of experience in the specialty chemicals industry 7* Manufacturing facilities 332,100* MTPA Capacity Installed 4* R&D Facilities 26% Revenue CAGR % (FY19-25) 20% PAT CAGR % (FY19-25) Rossari is a Specialty-Chemical manufacturer pro
Slide 18: A 25-Year Journey of Transformation
A 25-Year Journey of Transformation Delivering Value and Maintaining Synergy Along the Way Looking back in time Our Company was initially incorporated as ‘Rossari Labtech’ in March, 2003, as a partnership firm. In the same year, in December, the name of the partnership firm was changed to ‘Rossari B
Slide 19: Business Overview
Business Overview One of the leading specialty chemicals manufacturer delivering differentiated & tailor-made solutions across Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC) and Animal Health and Nutrition (AHN) businesses HPPC TSC AHN • One of the fastest-gr
Slide 20: Strengthening Market Presence
Strengthening Market Presence Strong and long-standing relationships with several clients and distributors spanning 15+ years Increasingly tapping new segments across domestic and 1 international markets 2 Building direct touch-points with several clients Growing client base of over 1,000 customers
Slide 21: Robust Manufacturing Capabilities
Robust Manufacturing Capabilities Unitop Dahej Plant Manufacturing Facility at Silvassa 60,000 MTPA • Located on 8.6 acres of land • Fungible manufacturing capabilities for powders, granules and liquids Tristar Sarigam Plant • Facility has a comprehensive range of testing & packaging capabilities •
Slide 22: Global Reach
Global Reach Market Presence RoW India 27% 73% EXPORT OPERATIONS IN 70+ COUNTRIES COLLABORATE. INNOVATE. ELEVATE.
Slide 23: Growth Drivers
Growth Drivers Augmenting product Increasing wallet share 01 portfolio 04 and customer base • Enhance emphasis on green/sustainable • Cross-sell and address sourcing solutions requirements of MNC customers • Leverage R&D capabilities to develop new • Tap into new customer segments niches in product
Slide 24: Update on Key Subsidiaries
Update on Key Subsidiaries Executed synergistic acquisitions in the past complementing the ethos of Rossari’s business model Revenue (Rs. crore) CAGR – 19% • Unitop solutions sold across 25+ countries • Presence in high-potential Specialty chemical segments, such as 774 651 Agrochemicals and Oil & G
Slide 25: Key Synergies from Acquisitions
Key Synergies from Acquisitions Strategic & value-accretive acquisitions accelerate growth and drive economies of scale Augmented presence in Specialty Chemical, Personal Care and Agrochemical segments Expansion of addressable domestic and export markets and end-user applications Extension of manufa
Slide 26: Strategies: Responses to Opportunities
Strategies Strategic Responses to Opportunities Opportunity Outcomes 1. Expanding into New Business Lines • Leverage existing R&D capabilities and expertise in core • Diversified revenue streams, reduced risk from chemistries to diversify into new product segments. dependence on core segments. • Exp
Slide 27: Strategies: Responses to Opportunities
Strategies Strategic Responses to Opportunities Opportunity Outcomes 4. Enhancing Sustainability and Green Initiatives • Invest in research and development of advanced sustainable • Strengthened brand reputation as an environmentally chemical solutions. responsible company. • Explore opportunities i
Slide 28: Strategies: Responses to Threats
Strategies Strategic Responses to Threats Threats Outcomes 1. Increasing Competition • Entry of new players or intensified competition from existing rivals in the • Drive for innovation and development of differentiated products specialty chemicals market. • Competition from low-cost producers, espe
Slide 29: Focus on Green & Sustainable Chemical Solutions since Inception
Focus on Green & Sustainable Chemical Solutions since Inception Aggressively embracing sustainability in business operations to accelerate growth Specialists in producing environmentally-benign substitutes that replace legacy and harmful products Focus on green, sustainable and cost neutral products
Slide 30: New Projects at the Dahej Plant
New Projects at the Dahej Plant
Slide 31: Corporate Social Responsibility
Corporate Social Responsibility We at Rossari, recognize our role and responsibility to deliver superior and sustainable value to our customers, business partners, employees and communities. We have implemented various CSR initiatives with employee volunteers as well as in partnership with implement
Slide 32: Experienced Promoters and Board of Directors
Experienced Promoters and Board of Directors Founders & Promoters Independent Directors • Over 25 years of experience in the banking industry. He holds a bachelor’s degree in commerce • B. Sc. (chemistry major) from K. J. Somaiya College of Science, from H. L. Commerce College, Gujarat University. H
Slide 33: Conference Call Details
CONFERENCE CALL DETAILS Q4 FY-2025 Earnings Conference Call Time 5:00 PM IST on Monday, April 28, 2025 Pre-registration To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Diamond Pass Registration (choruscall.
Slide 34: About Us
About Us Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Specialty-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, India, the Company operates strategically located manufacturing facilities at Silvas
Slide 35: Thank you
Thank y#u ‘aking you more competitive